Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Malignant Neoplasms of Female Genital Organs: early-phase trial registry

1 of 6 indexed Malignant Neoplasms of Female Genital Organs trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

6 US clinical trials · 1 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Malignant Neoplasms of Female Genital Organs: 6 US clinical trials tracked, 1 recruiting.

Malignant Neoplasms of Female Genital Organs is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most active sponsor is M.D. Anderson Cancer Center, running 6 of these trials.

Enrollment posture brief

Registry condition malignant-neoplasms-of-female-genital-organs

OPEN 1 | RECR 17% | LATE 0 | EARLY 5 | RANK #2866 | SPON 6

Volume-matched condition peers

Nearest open-share peer: Acute Renal Failure (17% recruiting · 6 trials)

Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%Malignant Neoplasms of F (th…17%
Open-enrollment share among volume-matched conditions near Malignant Neoplasms of Female Genital Organs

Malignant Neoplasms of Female Genital Organs lists 1 open slots (17% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Malignant Neoplasms of Female Genital Organs on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Malignant Neoplasms of Female Genital Organs is recruiting below its size-band peers.

    1 of 6 indexed trials (16.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Malignant Neoplasms of Female Genital Organs research.

    M.D. Anderson Cancer Center accounts for 6 of 6 trials (100%). 1 distinct sponsors appear on at least one study for this condition label.

  3. Most Malignant Neoplasms of Female Genital Organs trials plan to enrol fewer than 100 people.

    Median target enrolment is 35 among the 6 trials that report a genuine target (sentinel values excluded). 6 of those (100%) plan for fewer than 100 participants.

  4. Malignant Neoplasms of Female Genital Organs research is mostly interventional.

    6 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 13Phase 22

Phase Distribution

PhaseTrial count
Phase 1 3
Phase 2 2

Top Sponsors

M.D. Anderson Cancer Center 6 trials

Named interventions

Most-linked intervention names on Malignant Neoplasms of Female Genital Organs records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Fitness Test Behavioral
1 trials
Clostridium Novyi-NT Biological
1 trials
Selumetinib Drug
1 trials
Doxycycline Drug
1 trials
Aerobic Exercise Behavioral
1 trials
Accelerometer Device
1 trials
Questionnaires Behavioral
1 trials
Gemcitabine Drug
1 trials

US sites by state

Facility locations filed on Malignant Neoplasms of Female Genital Organs trials. A trial with sites in several states counts in each.

Texas 6 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Malignant Neoplasms of Female Genital Organs page

6 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Malignant Neoplasms of Female Genital Organs trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • M.D. Anderson Cancer Center sponsors the most Malignant Neoplasms of Female Genital Organs trials on record, review their full trial history before evaluating a specific study. See M.D. Anderson Cancer Center's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Malignant Neoplasms of Female Genital Organs condition card totals 6 registered trials; most-linked intervention Fitness Test; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.